Intervention Review

Inhaled hyperosmolar agents for bronchiectasis

  1. Anna Hart1,
  2. Karnam Sugumar2,
  3. Stephen J Milan3,*,
  4. Stephen J Fowler4,5,
  5. Iain Crossingham6

Editorial Group: Cochrane Airways Group

Published Online: 12 MAY 2014

Assessed as up-to-date: 2 APR 2014

DOI: 10.1002/14651858.CD002996.pub3


How to Cite

Hart A, Sugumar K, Milan SJ, Fowler SJ, Crossingham I. Inhaled hyperosmolar agents for bronchiectasis. Cochrane Database of Systematic Reviews 2014, Issue 5. Art. No.: CD002996. DOI: 10.1002/14651858.CD002996.pub3.

Author Information

  1. 1

    Lancaster University, Lancaster Medical School, Clinical Research Hub, Lancaster, Lancashire, UK

  2. 2

    Royal Preston Hospital, Lancashire Teaching Hospitals NHS Trust, Department of Paediatrics, Preston, UK

  3. 3

    St George's, University of London, Population Health Sciences and Education, London, UK

  4. 4

    University Hospital of South Manchester, University of Manchester, NIHR Respiratory and Allergy Clinical Research Facility, Manchester, UK

  5. 5

    Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK

  6. 6

    Royal Blackburn Hospital, Blackburn, Lancashire, UK

*Stephen J Milan, Population Health Sciences and Education, St George's, University of London, London, UK. s.milan@lancaster.ac.uk.

Publication History

  1. Publication Status: New search for studies and content updated (conclusions changed)
  2. Published Online: 12 MAY 2014

SEARCH